(2-(trimethylammonium)ethyl)methanethiosulfonate has been researched along with bilobalide in 1 studies
Studies ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Trials ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Recent Studies (post-2010) ((2-(trimethylammonium)ethyl)methanethiosulfonate) | Studies (bilobalide) | Trials (bilobalide) | Recent Studies (post-2010) (bilobalide) |
---|---|---|---|---|---|
143 | 0 | 17 | 165 | 5 | 59 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hawthorne, R; Lynch, JW | 1 |
1 other study(ies) available for (2-(trimethylammonium)ethyl)methanethiosulfonate and bilobalide
Article | Year |
---|---|
A picrotoxin-specific conformational change in the glycine receptor M2-M3 loop.
Topics: Allosteric Site; Cyclopentanes; Cysteine; Dimerization; Diterpenes; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; Furans; Ginkgolides; Glycine; Humans; Inhibitory Concentration 50; Kinetics; Mesylates; Mutagenesis, Site-Directed; Mutation; Picrotoxin; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Receptors, Glycine; Time Factors | 2005 |